RecruitingNCT06657430
A Study on the Preference of Risperidone Dosage Forms
Sponsor
Shanghai Mental Health Center
Enrollment
1,000 participants
Start Date
Sep 19, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.
Exclusion Criteria1
- Have difficulty reading and understanding Chinese or refuse to participate in the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06657430
Related Trials
Tolerability of MDMA in Schizophrenia
NCT057703751 location
rTMS for Depression in Young Adults With Autism
NCT049721361 location
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
NCT0688278555 locations
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
NCT037940761 location